Viewing Study NCT02225132


Ignite Creation Date: 2025-12-24 @ 9:49 PM
Ignite Modification Date: 2026-02-20 @ 12:38 PM
Study NCT ID: NCT02225132
Status: COMPLETED
Last Update Posted: 2019-08-06
First Post: 2014-08-23
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Assessment of Algorithm-Based Hydroxyurea Dosing on Fetal Hemoglobin Response, Acute Complications, and Organ Function in People With Sickle Cell Disease
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Sickle Cell Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hydroxyurea View
None Sickle Cell Disease View
None Fetal Hemoglobin Induction View